- Home
- ABBV vs CVX Comparison
ABBV vs CVX Comparison
Compare ABBV & CVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABBV
- CVX
- Stock Information
- Founded
- ABBV 2012
- CVX 1879
- Country
- ABBV United States
- CVX United States
- Employees
- ABBV N/A
- CVX N/A
- Industry
- ABBV Biotechnology: Pharmaceutical Preparations
- CVX Integrated oil Companies
- Sector
- ABBV Health Care
- CVX Energy
- Exchange
- ABBV Nasdaq
- CVX Nasdaq
- Market Cap
- ABBV 303.1B
- CVX 251.7B
- IPO Year
- ABBV N/A
- CVX N/A
- Fundamental
- Price
- ABBV $175.62
- CVX $142.70
- Analyst Decision
- ABBV Strong Buy
- CVX Buy
- Analyst Count
- ABBV 22
- CVX 18
- Target Price
- ABBV $207.45
- CVX $174.56
- AVG Volume (30 Days)
- ABBV 6.8M
- CVX 10.1M
- Earning Date
- ABBV 01-31-2025
- CVX 01-31-2025
- Dividend Yield
- ABBV 3.74%
- CVX 4.56%
- EPS Growth
- ABBV N/A
- CVX N/A
- EPS
- ABBV 2.87
- CVX 9.06
- Revenue
- ABBV $55,533,000,000.00
- CVX $191,689,000,000.00
- Revenue This Year
- ABBV $5.28
- CVX $2.34
- Revenue Next Year
- ABBV $5.73
- CVX N/A
- P/E Ratio
- ABBV $61.18
- CVX $15.76
- Revenue Growth
- ABBV 0.72
- CVX N/A
- 52 Week Low
- ABBV $153.09
- CVX $135.37
- 52 Week High
- ABBV $207.32
- CVX $167.11
- Technical
- Relative Strength Index (RSI)
- ABBV 47.03
- CVX 26.77
- Support Level
- ABBV $170.34
- CVX $155.17
- Resistance Level
- ABBV $178.13
- CVX $148.67
- Average True Range (ATR)
- ABBV 3.59
- CVX 2.87
- MACD
- ABBV 0.26
- CVX -2.10
- Stochastic Oscillator
- ABBV 40.68
- CVX 9.49
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
About CVX Chevron Corporation
Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.1 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.8 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2023 stood at 11.1 billion barrels of oil equivalent, including 6.0 billion barrels of liquids and 30.4 trillion cubic feet of natural gas.